162971-77-9 Usage
General Description
2-Hydroxy-3-(2-methyl-2-propenyl)benzaldehyde is a unique chemical compound with the molecular formula C11H12O2. It belongs to the class of organic compounds known as benzaldehydes, which are aromatic compounds containing a benzene ring in which one of the carbon atoms is substituted with a formyl (aldehyde) group. Specifically, it is characterized by the presence of a hydroxy group and a 2-methyl-2-propenyl group attached to the benzene ring. Like many benzaldehydes, this compound may have various applications in chemical research and synthesis. As it has an aldehyde group, it has the properties of a carbonyl compound and, with the presence of hydroxy group, it can potentially exhibit the capabilities of an alcohol too. However, specific properties and potential applications may depend on its precise chemical behavior, which can be influenced by surrounding conditions and reactions with other compounds.
Check Digit Verification of cas no
The CAS Registry Mumber 162971-77-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,6,2,9,7 and 1 respectively; the second part has 2 digits, 7 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 162971-77:
(8*1)+(7*6)+(6*2)+(5*9)+(4*7)+(3*1)+(2*7)+(1*7)=159
159 % 10 = 9
So 162971-77-9 is a valid CAS Registry Number.
InChI:InChI=1/C11H12O2/c1-8(2)6-9-4-3-5-10(7-12)11(9)13/h3-5,7,13H,1,6H2,2H3
162971-77-9Relevant articles and documents
Synthesis and cytotoxic activity of novel 2,6-disubstituted-4-mor- pholinothieno[3,2-d]pyrimidines as potent anti-tumor agents
Zhu, Wu Fu,Zhai, Xin,Li, Sai,Cao, Yun Yun,Gong, Ping,Liu, Ya Jing
, p. 703 - 706 (2012/07/16)
A series of 2,6-disubstituted-4-morpholinothieno[3,2-d]pyrimidine derivatives were synthesized and their cytotoxic activity against H460, HT-29, MDA-MB-231, U87MG and H1975 cancer cell lines were evaluated in vitro. Most of the target compounds exhibited moderate to excellent activity to the tested cell lines. The most promising compound 23 (0.84 μmol/L, 0.23 μmol/L, 2.52 μmol/L, 1.80 μmol/L) was 1.0, 2.9, 29.3 and 4.3 times more active than GDC-0941 (0.87 μmol/L, 0.66 μmol/L, 73.8 μmol/L, 7.77 μmol/L) against H460, HT-29, MDA-MB-231 and U87MG cell lines, respectively.